129 related articles for article (PubMed ID: 34336153)
1. miR-130-3p Promotes MTX-Induced Immune Killing of Hepatocellular Carcinoma Cells by Targeting EPHB4.
Shao L; Ye Q; Jia M
J Healthc Eng; 2021; 2021():4650794. PubMed ID: 34336153
[TBL] [Abstract][Full Text] [Related]
2. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
4. miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19.
Yao X; Zhang H; Liu Y; Liu X; Wang X; Sun X; Cheng Y
Gene; 2019 May; 698():141-149. PubMed ID: 30849536
[TBL] [Abstract][Full Text] [Related]
5. MTIF2 impairs 5 fluorouracil-mediated immunogenic cell death in hepatocellular carcinoma in vivo: Molecular mechanisms and therapeutic significance.
Xu D; Wang Y; Wu J; Zhang Z; Chen J; Xie M; Tang R; Cheng C; Chen L; Lin S; Luo X; Zheng J
Pharmacol Res; 2021 Jan; 163():105265. PubMed ID: 33129983
[TBL] [Abstract][Full Text] [Related]
6. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT.
Wang Y; Yang Z; Wang L; Sun L; Liu Z; Li Q; Yao B; Chen T; Wang C; Yang W; Liu Q; Han S
Biomed Pharmacother; 2019 Jan; 109():991-999. PubMed ID: 30551553
[TBL] [Abstract][Full Text] [Related]
7. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.
Li H; Wang N; Xu Y; Chang X; Ke J; Yin J
Bioengineered; 2022 Jan; 13(1):1304-1319. PubMed ID: 34983307
[TBL] [Abstract][Full Text] [Related]
8. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
9. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
Shi Y; Yan F; Wang F; Pan L
Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p.
Ye J; Tan L; Fu Y; Xu H; Wen L; Deng Y; Liu K
J Cell Biochem; 2019 Dec; 120(12):19775-19783. PubMed ID: 31310393
[TBL] [Abstract][Full Text] [Related]
12. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
[TBL] [Abstract][Full Text] [Related]
13. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
14. miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase.
Chen Z; Xiang B; Qi L; Zhu S; Li L
Cancer Biol Ther; 2020 Oct; 21(10):915-926. PubMed ID: 33023393
[TBL] [Abstract][Full Text] [Related]
15. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
Li Y; Jiang A
Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
[TBL] [Abstract][Full Text] [Related]
16. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
17. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1.
Sun Y; Shi P; Wu Q; Liu B; Yu Z; Jia H; Chang H
Hum Cell; 2021 Nov; 34(6):1788-1799. PubMed ID: 34273068
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
20. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
